|
Gesine Paul MD
Professor, Senior Consultant
Skånes University Hospital and Lund Unviersity
Lund
Sweden
|
"Gesine Paul is a Consultant Neurologist and Professor of Neurology at Lund University and Skåne University Hospital, Sweden.
She trained at the Charité in Berlin, UMDS in London and at started her research career at St Andrews University, Scotland. For several years she trained as neurologist at the Charité in Berlin before moving to Sweden. Attracted by Lund as a worldwide pioneering center for neurotransplantation, she joined the lab of Prof. Patrik Brundin in 2001 supported by an EU Marie Curie postdoctoral fellowship.
Since 2011 she leads a preclinical research group “Translational Neurology” at Lund University, Sweden with the aim to elucidate mechanisms of neurodegenerative disorders and identify novel targets for neuroprotection with a focus on blood-brain barrier pathology.
Gesine Paul is a clinical investigator in several frontline clinical trials in Parkinson’s disease addressing neurorestorative effect of growth factors (PDGF-BB, CDNF) and cell transplantation (fetal and stem-cell derived). She is the Principal Investigator of the newly started STEM-PD trial in Sweden, a multicentre, single arm, first in human trial, investigating the safety, tolerability and feasibility of intraputamenal transplantation of human embryonic stem cell-derived dopaminergic cells for Parkinson’s disease."
She trained at the Charité in Berlin, UMDS in London and at started her research career at St Andrews University, Scotland. For several years she trained as neurologist at the Charité in Berlin before moving to Sweden. Attracted by Lund as a worldwide pioneering center for neurotransplantation, she joined the lab of Prof. Patrik Brundin in 2001 supported by an EU Marie Curie postdoctoral fellowship.
Since 2011 she leads a preclinical research group “Translational Neurology” at Lund University, Sweden with the aim to elucidate mechanisms of neurodegenerative disorders and identify novel targets for neuroprotection with a focus on blood-brain barrier pathology.
Gesine Paul is a clinical investigator in several frontline clinical trials in Parkinson’s disease addressing neurorestorative effect of growth factors (PDGF-BB, CDNF) and cell transplantation (fetal and stem-cell derived). She is the Principal Investigator of the newly started STEM-PD trial in Sweden, a multicentre, single arm, first in human trial, investigating the safety, tolerability and feasibility of intraputamenal transplantation of human embryonic stem cell-derived dopaminergic cells for Parkinson’s disease."